drugset / Trial / NCT01388933

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

NCT01388933 ↗

Phase 2 Terminated 79 enrolled Tsumura USA Syneos Health · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Daikenchuto(TU-100)is effective in the treatment of Crohn's disease.

Timeline

Start
2011-09
Primary completion
2013-09
Completion
2013-09

Outcome

Outcome not reported

Stopped (Enrollment): “Study stopped due to low enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject TU-100 Traditional medicine (herbal / TCM) 5 g Oral

Indications